Motilal Oswal: Laurus Labs’ Sharp Ramp-Up In Q1 Earnings Led By Finished Dosage Forms And API 
The antiviral medication being manufactured in Russia. (Photographer Andrey Rudakov/Bloomberg)

Motilal Oswal: Laurus Labs’ Sharp Ramp-Up In Q1 Earnings Led By Finished Dosage Forms And API 

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportun...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.